title: Nitric oxide and endothelin in acute hypoxic pulmonary vasoconstriction and adaptation to chronic hypoxia.
authors.affiliation: Zeneca Pharmaceuticals, Wilmington, Delaware 19850-5437, USA.
authors.forename: W L
authors.initials: WL
authors.lastname: Rumsey
authors.forename: B M
authors.initials: BM
authors.lastname: Abbott
authors.forename: D L
authors.initials: DL
authors.lastname: Bertelsen
authors.forename: M A
authors.initials: MA
authors.lastname: DeSiato
mesh_terms: D000064:Acclimatization; D000208:Acute Disease; D000818:Animals; D000959:Antihypertensive Agents / Q000494:pharmacology*; D001794:Blood Pressure; D000077300:Bosentan; D002908:Chronic Disease; D004730:Endothelium, Vascular / Q000187:drug effects* / Q000502:physiology / Q000503:physiopathology; D000860:Hypoxia / Q000503:physiopathology*; D008297:Male; D019331:NG-Nitroarginine Methyl Ester / Q000494:pharmacology*; D019001:Nitric Oxide Synthase / Q000037:antagonists & inhibitors; D011651:Pulmonary Artery / Q000187:drug effects / Q000502:physiology / Q000503:physiopathology*; D051381:Rats; D017207:Rats, Sprague-Dawley; D013449:Sulfonamides / Q000494:pharmacology*; D014661:Vasoconstriction / Q000187:drug effects
chemical_list: D000959:Antihypertensive Agents; D013449:Sulfonamides; D019001:Nitric Oxide Synthase; D000077300:Bosentan; D019331:NG-Nitroarginine Methyl Ester